Breast cancer is recognized as a highly heterogeneous disease, which was distinguished distinct pathological subtypes through the expression of hormone receptors (HR) and human epidermal growth factor receptor 2 (HER2) (1). The gene discussed is ERBB2; the disease is breast carcinoma.